Plant Pigments for Human Health: Impact of Lycopene and Anthocyanins on Bioefficacy of Provitamin A Carotenoids From Carrots
Study Details
Study Description
Brief Summary
The proposed research will help characterize the impact that simultaneous consumption of anthocyanins and carotenoids has on the bioavailability of the provitamin A carotenoids a-carotene and b-carotene and the non-provitamin A carotenoid lycopene, and on their respective antidiabetic activity in humans. The central hypothesis is that provitamin A carotenoids will be bioavailable from purple-red multicolored carrots in humans, and the co-ingestion of carotenoids and anthocyanins from these carrots will have synergistic impacts on their respective antioxidant and antidiabetic effects. This hypothesis will be assessed through a 53 day randomized crossover time course study that consists of three arms in which healthy males and females ages 18-40 (n = 15) will consume carrot juice prepared from red, purple-red, or purple carrots. During each arm, participants will switch the type of juice they consume and by the end of the third arm, all participants will have ingested juice made from all three carrot varieties. Blood will be collected at multiple time points over 72 hours following consumption.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Starting with Purple-Red Carrot Juice Participants are randomized to consume purple-red carrot juice first (250 mL) in under 2 minutes. They will crossover to red carrot juice and to purple carrot juice. |
Other: Purple-Red Carrot Juice
Purple-Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), the non-provitamin A carotenoid, lycopene, as well as anthocyanins
Other: Red Carrot Juice
Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), and the non-provitamin A carotenoid, lycopene, but does NOT contain anthocyanins..
Other: Purple Carrot Juice
Purple carrot juice does NOT contain provitamin A carotenoids (beta-carotene, alpha-carotene), nor the non-provitamin A carotenoid, lycopene, but contains anthocyanins.
|
Active Comparator: Starting with Purple Carrot Juice Participants are randomized to consume purple carrot juice first (250 mL) in under 2 minutes. They will crossover to red carrot juice and to purple-red carrot juice. |
Other: Purple-Red Carrot Juice
Purple-Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), the non-provitamin A carotenoid, lycopene, as well as anthocyanins
Other: Red Carrot Juice
Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), and the non-provitamin A carotenoid, lycopene, but does NOT contain anthocyanins..
Other: Purple Carrot Juice
Purple carrot juice does NOT contain provitamin A carotenoids (beta-carotene, alpha-carotene), nor the non-provitamin A carotenoid, lycopene, but contains anthocyanins.
|
Active Comparator: Starting with Red Carrot Juice Participants are randomized to consume red carrot juice first (250 mL) in under 2 minutes. They will crossover to purple-red carrot juice and to purple carrot juice. |
Other: Purple-Red Carrot Juice
Purple-Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), the non-provitamin A carotenoid, lycopene, as well as anthocyanins
Other: Red Carrot Juice
Red carrot juice contains provitamin A carotenoids (beta-carotene, alpha-carotene), and the non-provitamin A carotenoid, lycopene, but does NOT contain anthocyanins..
Other: Purple Carrot Juice
Purple carrot juice does NOT contain provitamin A carotenoids (beta-carotene, alpha-carotene), nor the non-provitamin A carotenoid, lycopene, but contains anthocyanins.
|
Outcome Measures
Primary Outcome Measures
- Change in serum retinol concentration [Blood will be drawn on the first test day (treatment day) at baseline, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2.5 hours, 4 hours, 6 hours, 9 hours, 24 hours, 72 hours]
Blood draws will take place on the first, second, and fourth test day (days 8, 9, 11 of each arm)
- Change in serum carotenoid concentration [Blood will be drawn on the first test day (treatment day) at baseline, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2.5 hours, 4 hours, 6 hours, 9 hours, 24 hours, 72 hours]
Blood draws will take place on the first, second, and fourth test day (days 8, 9, 11 of each arm)
- Change in serum anthocyanin concentration [Blood will be drawn on the first test day (treatment day) at baseline, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2.5 hours, 4 hours, 6 hours, 9 hours, 24 hours, 72 hours]
Blood draws will take place on the first, second, and fourth test day (days 8, 9, 11 of each arm)
Secondary Outcome Measures
- Change in antioxidant capacity of the carrots and carrot juice measured by enzyme activity assay [up to 1 month]
Three different antioxidant activity assays will be used including the Oxygen Radical Absorbance Capacity (ORAC), 2,2'-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid (ABTS+), and 1,1-diphenyl-2-picrylhydrazyl (DPPH) assays, all of which will be analyzed by Ultraviolet (UV) spec. Each method analyzes different ways anthocyanins and carotenoids may act as antioxidants, and a combination of the three will more accurately represent the parameters of human biology. Data will be expressed as Trolox equivalent antioxidant capacity (TEAC).
- Change in alpha-glucosidase inhibition activities of the carrots and carrot juice measured by enzyme activity assay [up to 1 month]
Enzyme inhibition will be assessed using specific enzymatic assay kits for alpha-glucosidase and alpha-amylase, analyzed using Enzyme-Linked Immunosorbent Assay (ELISA), and results will be expressed as IC50 (% inhibition).
- Change in alpha-amylase inhibition activities of the carrots and carrot juice measured by enzyme activity assay [up to 1 month]
Enzyme inhibition will be assessed using specific enzymatic assay kits for alpha-glucosidase and alpha-amylase, analyzed using ELISA, and results will be expressed as IC50 (% inhibition).
- Change in serum glucose concentration [Blood will be drawn on the first test day (treatment day) at baseline, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2.5 hours, 4 hours, 6 hours, 9 hours, 24 hours, 72 hours]
Blood draws will take place on the first, second, and fourth test day (days 8, 9, 11 of each arm)
- Change in serum insulin concentration [Blood will be drawn on the first test day (treatment day) at baseline, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2.5 hours, 4 hours, 6 hours, 9 hours, 24 hours, 72 hours]
Blood draws will take place on the first, second, and fourth test day (days 8, 9, 11 of each arm)
- Change in serum incretin concentration [Blood will be drawn on the first test day (treatment day) at baseline, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2.5 hours, 4 hours, 6 hours, 9 hours, 24 hours, 72 hours]
Blood draws will take place on the first, second, and fourth test day (days 8, 9, 11 of each arm)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Healthy
-
Non-smoking
-
Not pregnant (or planning to become pregnant)
-
Body Mass Index (BMI) greater than 18.5 and less than 30
Exclusion Criteria:
-
Major comorbidities (cardiovascular disease (CVD), diabetes, cancer, kidney/liver/bowel disease)
-
History of malabsorptive/GI disorders
-
Abnormal diet
-
BMI less than 18.5 or greater than 30
-
Food intolerances/allergies/hypersensitivities
-
History of substance abuse or alcoholism
-
Unwilling to restrict consumption of specific foods prior to study
-
Unwilling to participate in blood draws
-
History of difficulty drawing blood/health issues associated with blood draws (gets dizzy, etc).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UW-Madison Department of Nutritional Sciences | Madison | Wisconsin | United States | 53706 |
Sponsors and Collaborators
- University of Wisconsin, Madison
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-1544
- Protocol Version 6/9/2022
- A074600